AAAAAA
Results:
1-11
|
Results: 11
Authors:
Dolle, F
Valette, H
Hinnen, F
Demphel, S
Bramoulle, Y
Peglion, JL
Crouzel, C
Citation: F. Dolle et al., Highly efficient synthesis of [C-11]S12968 and [C-11]S12967, for the in vivo imaging of the cardiac calcium channels using PET, J LABEL C R, 44(7), 2001, pp. 481-499
Authors:
Dolle, F
Hinnen, F
Vaufrey, F
Demphel, S
Bramoulle, Y
Fournier, D
Ponchant, M
Valette, H
Crouzel, C
Citation: F. Dolle et al., Highly efficient synthesis of [C-11]Me-QNB, a selective radioligand for the quantification of the cardiac muscarinic receptors using PET, J LABEL C R, 44(5), 2001, pp. 337-345
Authors:
Dolle, F
Valette, H
Hinnen, F
Vaufrey, F
Demphel, S
Coulon, C
Ottaviani, M
Bottlaender, M
Crouzel, C
Citation: F. Dolle et al., Synthesis and preliminary evaluation of a carbon-11-labelled agonist of the alpha 7 nicotinic acetylcholine receptor, J LABEL C R, 44(11), 2001, pp. 785-795
Authors:
Poyot, T
Conde, F
Gregoire, MC
Frouin, V
Coulon, C
Fuseau, C
Hinnen, F
Dolle, F
Hantraye, P
Bottlaender, M
Citation: T. Poyot et al., Anatomic and biochemical correlates of the dopamine transporter ligand C-11-PE2I in normal and parkinsonian primates: Comparison with 6-[F-18] Fluoro-L-Dopa, J CEREBR B, 21(7), 2001, pp. 782-792
Authors:
Valette, H
Dolle, F
Guenther, I
Hinnen, F
Fuseau, C
Coulon, C
Peglion, JL
Crouzel, C
Citation: H. Valette et al., Myocardial kinetics of the C-11-labeled enantiomers of the Ca2+ channel inhibitor S11568: An in vivo study, J NUCL MED, 42(6), 2001, pp. 932-937
Authors:
Martinot, MLP
Bragulat, V
Artiges, E
Dolle, F
Hinnen, F
Jouvent, R
Martinot, JL
Citation: Mlp. Martinot et al., Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation, AM J PSYCHI, 158(2), 2001, pp. 314-316
Authors:
Kuhnast, B
Dolle, F
Terrazzino, S
Rousseau, B
Loc'h, C
Vaufrey, F
Hinnen, F
Doignon, I
Pillon, F
David, C
Crouzel, C
Tavitian, B
Citation: B. Kuhnast et al., General method to label antisense oligonucleotides with radioactive halogens for pharmacological and imaging studies, BIOCONJ CHE, 11(5), 2000, pp. 627-636
Authors:
Kuhnast, B
Dolle, F
Vaufrey, F
Hinnen, F
Crouzel, C
Tavitian, B
Citation: B. Kuhnast et al., Fluorine-18 labeling of oligonucleotides bearing chemically-modified ribose-phosphate backbones, J LABEL C R, 43(8), 2000, pp. 837-848
Authors:
Valette, H
Dolle, F
Guenther, I
Demphel, S
Rasetti, C
Hinnen, F
Fuseau, C
Crouzel, C
Citation: H. Valette et al., Preliminary evaluation of 2-[4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone ([+/-]HX-CH 44) as a selective beta 1-adrenoceptor ligand for PET, NUCL MED BI, 26(1), 1999, pp. 105-109
Authors:
Dolle, F
Dolci, L
Valette, H
Hinnen, F
Vaufrey, F
Guenther, I
Fuseau, C
Coulon, C
Bottlaender, M
Crouzel, C
Citation: F. Dolle et al., Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: A new positron emission tomography ligand for nicotinic receptors, J MED CHEM, 42(12), 1999, pp. 2251-2259
Characterization of the nicotinic ligand 2-[F-18]fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine in vivo
Authors:
Valette, H
Bottlaender, M
Dolle, F
Guenther, I
Coulon, C
Hinnen, F
Fuseau, C
Ottaviani, M
Crouzel, C
Citation: H. Valette et al., Characterization of the nicotinic ligand 2-[F-18]fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine in vivo, LIFE SCI, 64(5), 1998, pp. PL93-PL97
Risultati:
1-11
|